Why the study?
Is angiotensinogen gene (AGT) variation associated with susceptibility to preeclampsia/eclampsia in Australian and Chinese populations?
Is angiotensinogen gene (AGT) variation associated with susceptibility to preeclampsia/eclampsia in Australian and Chinese populations?
Angiotensinogen gene variation does not appear to be significantly associated with preeclampsia/eclampsia in Australian or Chinese populations, challenging earlier reports.
AGT variation should not inform PE/E risk assessment; challenges earlier reports but leaves open ancestry-specific effects.
Preeclampsia/eclampsia (PE/E) is a common disease of human pregnancy with a strong genetic component. The etiology of PE/E is unknown. Two recent reports indicated that the angiotensinogen gene (AGT) could be involved in susceptibility to PE/E. We performed a population-based case-control study in Australian and Chinese populations to investigate whether AGT is a good candidate gene for PE/E. A microsatellite polymorphism within AGT was typed as well as a molecular variant T235 (Met-->Thr) of AGT using allele-specific PCR and allele-induced restriction site PCR. The allele distributions of the microsatellite and the variant T235 of AGT were significantly different between the two ethnic groups. However, no significant allele associations were found with disease when comparing PE/E patients and controls in Australian or Chinese populations, which is in contrast to the two earlier reports. The results suggest that the contribution of AGT to the occurrence of PE/E is small, if anything, and is not constant across populations.
No takes yet. Share an insight, caveat, or question.
Guo et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: